Skip to content

Research at St Andrews

COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries

Research output: Contribution to journalArticlepeer-review

Author(s)

Julio S. Solís Arce, Shana S. Warren, Niccolò F. Meriggi, Alexandra Scacco, Nina McMurry, Maarten Voors, Georgiy Syunyaev, Amyn Abdul Malik, Samya Aboutajdine, Opeyemi Adeojo, Deborah Anigo, Alex Armand, Saher Asad, Martin Atyera, Britta Augsburg, Manisha Awasthi, Gloria Eden Ayesiga, Antonella Bancalari, Martina Björkman Nyqvist, Ekaterina Borisova & 54 more Constantin Manuel Bosancianu, Magarita Rosa Cabra García, Ali Cheema, Elliott Collins, Filippo Cuccaro, Ahsan Zia Farooqi, Tatheer Fatima, Mattia Fracchia, Mery Len Galindo Soria, Andrea Guariso, Ali Hasanain, Sofía Jaramillo, Sellu Kallon, Anthony Kamwesigye, Arjun Kharel, Sarah Kreps, Madison Levine, Rebecca Littman, Mohammad Malik, Gisele Manirabaruta, Jean Léodomir Habarimana Mfura, Fatoma Momoh, Alberto Mucauque, Imamo Mussa, Jean Aime Nsabimana, Isaac Obara, María Juliana Otálora, Béchir Wendemi Ouédraogo, Touba Bakary Pare, Melina R. Platas, Laura Polanco, Javaeria Ashraf Qureshi, Mariam Raheem, Vasudha Ramakrishna, Ismail Rendrá, Taimur Shah, Sarene Eyla Shaked, Jacob N. Shapiro, Jakob Svensson, Ahsan Tariq, Achille Mignondo Tchibozo, Hamid Ali Tiwana, Bhartendu Trivedi, Corey Vernot, Pedro C. Vicente, Laurin B. Weissinger, Basit Zafar, Baobao Zhang, Dean Karlan, Michael Callen, Matthieu Teachout, Macartan Humphreys, Ahmed Mushfiq Mobarak, Saad B. Omer

School/Research organisations

Abstract

Widespread acceptance of COVID-19 vaccines is crucial for achieving sufficient immunization coverage to end the global pandemic, yet few studies have investigated COVID-19 vaccination attitudes in lower-income countries, where large-scale vaccination is just beginning. We analyze COVID-19 vaccine acceptance across 15 survey samples covering 10 low- and middle-income countries (LMICs) in Asia, Africa and South America, Russia (an upper-middle-income country) and the United States, including a total of 44,260 individuals. We find considerably higher willingness to take a COVID-19 vaccine in our LMIC samples (mean 80.3%; median 78%; range 30.1 percentage points) compared with the United States (mean 64.6%) and Russia (mean 30.4%). Vaccine acceptance in LMICs is primarily explained by an interest in personal protection against COVID-19, while concern about side effects is the most common reason for hesitancy. Health workers are the most trusted sources of guidance about COVID-19 vaccines. Evidence from this sample of LMICs suggests that prioritizing vaccine distribution to the Global South should yield high returns in advancing global immunization coverage. Vaccination campaigns should focus on translating the high levels of stated acceptance into actual uptake. Messages highlighting vaccine efficacy and safety, delivered by healthcare workers, could be effective for addressing any remaining hesitancy in the analyzed LMICs.
Close

Details

Original languageEnglish
Number of pages21
JournalNature Medicine
VolumeFirst Online
Early online date16 Jul 2021
DOIs
Publication statusE-pub ahead of print - 16 Jul 2021

    Research areas

  • COVID-19

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Coordination and the Poor Maintenance Trap: an Experiment on Public Infrastructure in India

    Bancalari, A., Jun 2021, The Centre for Economic Policy Research (CEPR).

    Research output: Working paper

  2. Can white elephants kill? Unintended consequences of infrastructure development in Peru

    Bancalari, A., 28 Sep 2019, Institute for Fiscal Studies, (IFS Working Paper).

    Research output: Working paper

Related by journal

  1. First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

    Simpson, C. R., Shi, T., Vasileiou, E., Katikireddi, S. V., Kerr, S., Moore, E., McCowan, C., Agrawal, U., Shah, S. A., Ritchie, L. D., Murray, J., Pan, J., Bradley, D. T., Stock, S. J., Wood, R., Chuter, A., Beggs, J., Stagg, H. R., Joy, M., Tsang, R. S. M. & 10 others, de Lusignan, S., Hobbs, R., Lyons, R. A., Torabi, F., Bedston, S., O'Leary, M., Akbari, A., McMenamin, J., Robertson, C. & Sheikh, A., 9 Jun 2021, (E-pub ahead of print) In: Nature Medicine. 16 p.

    Research output: Contribution to journalArticlepeer-review

  2. Deciphering the genomic, epigenomic and transcriptomic landscapes of pre-invasive lung cancer lesions

    Texeira, V. H., Pipinikas, C. P., Pennycuick, A., Lee-Six, H., Chandrasekharan, D., Beane, J., Morris, T. J., Karpathakis, A., Feber, A., Breeze, C. E., Ntolios, P., Hynds, R. E., Falzon, M., Capitanio, A., Carroll, B., Durrenberger, P. F., Hardavella, G., Brown, J. M., Lynch, A. G., Farmery, H. & 12 others, Paul, D. S., Chambers, R. C., McGranahan, N., Navani, N., Thakrar, R. M., Swanton, C., Beck, S., George, P. J., Spira, A., Campbell, P. J., Thirwell, C. & Janes, S. M., Mar 2019, In: Nature Medicine. 25, 3, p. 517-525 9 p.

    Research output: Contribution to journalArticlepeer-review

  3. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer’s disease

    Du, H., Guo, L., Fang, F., Chen, D., Sosunov, A., McKhann, G., Yan, Y., Wang, C., Zhang, H., Molkentin, J., Gunn-Moore, F. J., Vonsattel, JP., Arancio, O., Chen, JX. & Yan, SD., Oct 2008, In: Nature Medicine. 14, 10, p. 1097-1105 9 p.

    Research output: Contribution to journalArticlepeer-review

  4. Extinct 1918 virus comes alive

    Lamb, R. A. & Jackson, D., Nov 2005, In: Nature Medicine. 11, 11, p. 1154-1156 3 p.

    Research output: Contribution to journalArticlepeer-review

ID: 275153943

Top